NO994339D0 - Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat - Google Patents

Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat

Info

Publication number
NO994339D0
NO994339D0 NO994339A NO994339A NO994339D0 NO 994339 D0 NO994339 D0 NO 994339D0 NO 994339 A NO994339 A NO 994339A NO 994339 A NO994339 A NO 994339A NO 994339 D0 NO994339 D0 NO 994339D0
Authority
NO
Norway
Prior art keywords
alfa
preparation
pharmaceutical composition
acid glycoprotein
glycoprotein
Prior art date
Application number
NO994339A
Other languages
English (en)
Other versions
NO994339L (no
Inventor
Ludwig Pichler
Eva-Maria Muchitisch
Anton Philapitsch
Hans-Peter Schwarz
Yendra Linnau
Wolfgang Teschner
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO994339D0 publication Critical patent/NO994339D0/no
Publication of NO994339L publication Critical patent/NO994339L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO994339A 1997-03-10 1999-09-07 Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat NO994339L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0040997A AT405241B (de) 1997-03-10 1997-03-10 Verwendung von humanem alpha1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation
PCT/AT1998/000060 WO1998040087A2 (de) 1997-03-10 1998-03-10 VERWENDUNG VON HUMANEM α1-SAUREN GLYCOPROTEIN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN PRÄPARATION

Publications (2)

Publication Number Publication Date
NO994339D0 true NO994339D0 (no) 1999-09-07
NO994339L NO994339L (no) 1999-11-08

Family

ID=3489866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994339A NO994339L (no) 1997-03-10 1999-09-07 Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat

Country Status (14)

Country Link
EP (1) EP0967986B1 (no)
JP (1) JP2001514629A (no)
AT (2) AT405241B (no)
AU (1) AU6284198A (no)
BR (1) BR9808000A (no)
CA (1) CA2283580A1 (no)
DE (1) DE59805897D1 (no)
DK (1) DK0967986T3 (no)
ES (1) ES2185147T3 (no)
HU (1) HUP0100639A3 (no)
NO (1) NO994339L (no)
PT (1) PT967986E (no)
SK (1) SK120299A3 (no)
WO (1) WO1998040087A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408946B (de) * 1999-02-18 2002-04-25 Immuno Ag Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
AT407485B (de) * 1999-04-14 2001-03-26 Haemosan Erzeugung Pharmazeuti Neue medizinische verwendung von alpha1-saurem glykoprotein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06118723A (ja) * 1992-10-02 1994-04-28 Fujitsu Ltd 電子写真用キャリア
JPH06122025A (ja) * 1992-10-14 1994-05-06 Komatsu Ltd プレスブレーキロボットシステムのワーク曲げ追従方法

Also Published As

Publication number Publication date
AU6284198A (en) 1998-09-29
DE59805897D1 (de) 2002-11-14
ES2185147T3 (es) 2003-04-16
ATE225664T1 (de) 2002-10-15
JP2001514629A (ja) 2001-09-11
AT405241B (de) 1999-06-25
ATA40997A (de) 1998-11-15
DK0967986T3 (da) 2003-02-10
EP0967986A2 (de) 2000-01-05
NO994339L (no) 1999-11-08
PT967986E (pt) 2003-02-28
EP0967986B1 (de) 2002-10-09
WO1998040087A2 (de) 1998-09-17
HUP0100639A3 (en) 2001-09-28
SK120299A3 (en) 2000-05-16
BR9808000A (pt) 2000-03-08
HUP0100639A1 (hu) 2001-08-28
WO1998040087A3 (de) 1998-12-17
CA2283580A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
DE60004974D1 (de) Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
TR199902071T2 (xx) Heterosiklik bile�ikler ve bunlar�n �-amilioid peptidinin inhibisyonunda kullan�m�
BG104247A (en) Resorcinol derivatives
ATE243694T1 (de) 4-mercaptoacetylamino-(2)benzazepinon(3)- derivate, und verwendung als enkephalinase- inhibitoren
DE69106586T2 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
FI965144A0 (fi) Sterolijohdannaiset käytettäviksi meioosin säätelyyn
DE69924375D1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
NO307687B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
SE9801494D0 (sv) Novel use
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ATE182586T1 (de) Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
FI964045A0 (fi) CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
NO994339L (no) Anvendelse av &lt;alfa&gt;1-surt glykoprotein ved fremstilling av et farmasöytisk preparat
NO982562D0 (no) Sammensetning for behandling av smerte
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
DE689838T1 (de) Verwendung von Diademosim 5&#39;,5&#39;&#39;&#39;-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
IT1312060B1 (it) Uso dell&#39;acido alfa lipoico nel trattamento antimetastatico.
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application